David A. Schwartz

17.8k total citations · 1 hit paper
328 papers, 10.7k citations indexed

About

David A. Schwartz is a scholar working on Surgery, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David A. Schwartz has authored 328 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Surgery, 101 papers in Genetics and 85 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David A. Schwartz's work include Inflammatory Bowel Disease (93 papers), Head and Neck Cancer Studies (56 papers) and Diverticular Disease and Complications (41 papers). David A. Schwartz is often cited by papers focused on Inflammatory Bowel Disease (93 papers), Head and Neck Cancer Studies (56 papers) and Diverticular Disease and Complications (41 papers). David A. Schwartz collaborates with scholars based in United States, Canada and Spain. David A. Schwartz's co-authors include William J. Sandborn, Adam S. Garden, David Schreiber, William J. Tremaine, Alan R. Zinsmeister, Joseph G. Rajendran, David I. Rosenthal, Paul E. Wise, William H. Morrison and Edward V. Loftus and has published in prestigious journals such as Science, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

David A. Schwartz

320 papers receiving 10.4k citations

Hit Papers

The natural history of fistulizing Crohn's disease in Olm... 2002 2026 2010 2018 2002 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Schwartz United States 57 4.5k 2.6k 2.5k 1.9k 1.7k 328 10.7k
Wei Xu Canada 52 2.4k 0.5× 824 0.3× 2.4k 0.9× 2.6k 1.4× 584 0.3× 400 9.6k
Jonas T. Johnson United States 74 9.4k 2.1× 852 0.3× 3.6k 1.4× 7.6k 3.9× 1.1k 0.6× 484 19.6k
William E. Gooding United States 75 3.1k 0.7× 794 0.3× 4.3k 1.7× 2.3k 1.2× 1.0k 0.6× 283 17.2k
Carol R. Bradford United States 72 6.0k 1.3× 496 0.2× 3.7k 1.4× 7.2k 3.7× 1.0k 0.6× 353 16.8k
Harm van Tinteren Netherlands 69 6.1k 1.4× 574 0.2× 5.7k 2.2× 461 0.2× 2.1k 1.2× 340 17.1k
Loren K. Mell United States 50 2.9k 0.6× 200 0.1× 2.4k 0.9× 1.2k 0.6× 1.6k 0.9× 243 8.9k
John A. Ridge United States 48 6.8k 1.5× 491 0.2× 4.6k 1.8× 9.9k 5.1× 872 0.5× 207 15.2k
Harold Kim Canada 35 3.0k 0.7× 407 0.2× 2.3k 0.9× 4.5k 2.3× 644 0.4× 153 9.7k
Rosemarie Mick United States 72 2.0k 0.4× 636 0.2× 2.6k 1.0× 808 0.4× 930 0.5× 265 14.4k
Helmuth Goepfert United States 70 7.8k 1.7× 1.6k 0.6× 4.0k 1.6× 7.5k 3.8× 490 0.3× 239 17.5k

Countries citing papers authored by David A. Schwartz

Since Specialization
Citations

This map shows the geographic impact of David A. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Schwartz more than expected).

Fields of papers citing papers by David A. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Schwartz. The network helps show where David A. Schwartz may publish in the future.

Co-authorship network of co-authors of David A. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Schwartz. A scholar is included among the top collaborators of David A. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Schwartz. David A. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reinisch, Walter, Jean‐Frédéric Colombel, Geert D’Haens, et al.. (2024). Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn’s Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial. Journal of Crohn s and Colitis. 18(6). 864–874. 11 indexed citations
2.
Michalski, Jeff M., Jennifer Moughan, James A. Purdy, et al.. (2023). Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S4–S5. 3 indexed citations
3.
Pabla, Baldeep, James C. Slaughter, Elizabeth Scoville, et al.. (2021). Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience. Digestive Diseases and Sciences. 67(7). 3129–3137. 11 indexed citations
4.
Goepfert, Ryan P., Jan S. Lewin, Martha P. Barrow, et al.. (2016). Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in “Low-Intermediate Risk” Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 97(4). 700–708. 44 indexed citations
5.
Mao, Weihua, Weiguo Lu, Xuejun Gu, et al.. (2016). Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning. Journal of Applied Clinical Medical Physics. 18(1). 157–163. 5 indexed citations
6.
Osborn, Virginia, David A. Schwartz, Yi-Chun Lee, et al.. (2016). Patterns of care of IMRT usage in postoperative management of uterine cancer. Gynecologic Oncology. 144(1). 130–135. 7 indexed citations
7.
Wong, Andrew T., et al.. (2016). Adjuvant radiation with hormonal therapy is associated with improved survival in men with pathologically involved lymph nodes after radical surgery for prostate cancer. Urologic Oncology Seminars and Original Investigations. 34(12). 529.e15–529.e20. 17 indexed citations
8.
Feagan, B G, David A. Schwartz, Silvio Danese, et al.. (2015). P506. Predictors of Health-related Quality of Life in Asian Patients with Inflammatory Bowel Disease: Psychological, Clinical and Demographic factors. Journal of Crohn s and Colitis. 9(suppl 1). S332–S333. 1 indexed citations
9.
Chun, Stephen G., Hyunsil Park, Raj K. Pandita, et al.. (2015). Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers. Europe PMC (PubMed Central). 3 indexed citations
10.
Schreiber, David, Andrew T. Wong, Justin Rineer, Jeremy Weedon, & David A. Schwartz. (2015). Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study. Journal of Clinical Pathology. 68(6). 453–457. 23 indexed citations
11.
Schreiber, David, et al.. (2014). Dose-escalated radiation therapy with and without short-course androgen deprivation for intermediate-risk prostate cancer.. PubMed. 34(8). 4189–93. 4 indexed citations
12.
Kesan, Jay P., David A. Schwartz, & Ted M. Sichelman. (2012). Paving the Path to Predicting Legal Outcomes: A Response to Professor Chien's Predicting Patent Litigation. Texas law review. 90. 97–109. 1 indexed citations
13.
Moeller, Benjamin J., John S. Yordy, Michelle D. Williams, et al.. (2011). DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy. Clinical Cancer Research. 17(7). 2035–2043. 75 indexed citations
14.
Chen, Yunyun, Daisuke Sano, Mitchell J. Frederick, et al.. (2011). Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model. Clinical Cancer Research. 17(8). 2281–2291. 68 indexed citations
15.
Diagaradjane, Parmeswaran, Amit Deorukhkar, Shujun Shentu, et al.. (2008). Imaging Epidermal Growth Factor Receptor Expression In vivo : Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe. Clinical Cancer Research. 14(3). 731–741. 143 indexed citations
16.
Wise, Paul E., et al.. (2008). A Randomized Prospective Trial of Endoscopic Ultrasound to Guide Combination Medical and Surgical Treatment for Crohn's Perianal Fistulas. The American Journal of Gastroenterology. 103(10). 2527–2535. 65 indexed citations
17.
Schwartz, David A., et al.. (2007). Metastatic signet-ring carcinoma of the colon diagnosed by EUS-guided FNA in a patient with Crohn's disease. Gastrointestinal Endoscopy. 65(6). 945–947. 2 indexed citations
18.
Sands, Bruce E., William J. Sandborn, Douglas C. Wolf, et al.. (2004). PILOT STUDY ON THE SAFETY AND EFFICACY OF GRANULOCYTE/MONOCYTE ADSORPTION APHERESIS WITH ADACOLUMN IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. The American Journal of Gastroenterology. 99. S263–S264. 1 indexed citations
19.
Schwartz, David A., Joseph G. Rajendran, Bevan Yueh, et al.. (2003). Staging of Head and Neck Squamous Cell Cancer With Extended-Field FDG-PET. Archives of Otolaryngology - Head and Neck Surgery. 129(11). 1173–1173. 93 indexed citations
20.
Schwartz, David A., Maurits Wiersema, Kika M. Dudiak, et al.. (2001). Managing uninvestigated dyspepsia: What is the value of “negative” endoscopy?. Gastrointestinal Endoscopy. 53(5). AB69–AB69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026